.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Johnson and Johnson
Covington
Cerilliant
Dow
Citi
Boehringer Ingelheim
Daiichi Sankyo
Novartis
Federal Trade Commission

Generated: June 22, 2017

DrugPatentWatch Database Preview

Istituto Bio Ita Spa Company Profile

« Back to Dashboard

Summary for Applicant: Istituto Bio Ita Spa

Patents:1
Tradenames:7
Ingredients:7
NDAs:13
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Istituto Bio Ita Spa
OXACILLIN SODIUM
oxacillin sodium
INJECTABLE;INJECTION062798-001Dec 11, 1995DISCNNoNo► Subscribe► Subscribe
Istituto Bio Ita Spa
AMPICILLIN SODIUM
ampicillin sodium
INJECTABLE;INJECTION062719-001May 12, 1987APRXNoNo► Subscribe► Subscribe
Istituto Bio Ita Spa
PIPERACILLIN AND TAZOBACTAM
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION065523-003May 31, 2011APRXNoNo► Subscribe► Subscribe
Istituto Bio Ita Spa
PIPERACILLIN
piperacillin sodium
INJECTABLE;INJECTION065114-003Nov 14, 2003RXNoYes► Subscribe► Subscribe
Istituto Bio Ita Spa
AMPICILLIN SODIUM
ampicillin sodium
INJECTABLE;INJECTION201404-001Dec 20, 2013APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Novartis
Boehringer Ingelheim
Harvard Business School
Dow
US Department of Justice
McKinsey
AstraZeneca
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot